MedPath

DOXAZOSINA NEO AUROVITAS SPAIN 4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG

DOXAZOSINA NEO AUROVITAS SPAIN 4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG

Commercialized
Register Number

70679

Prescription Type

Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración

Authorization Date

Oct 7, 2009

Dosage Form

COMPRIMIDO DE LIBERACIÓN PROLONGADA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number70679
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

DOXAZOSINAActive
Quantity: 4,00 mg
Name: DOXAZOSINA

ATC CLASSIFICATION (3)

C02C
C02CA
C02CA04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.